Received by email:

File: 2016-12-15  - Stock Options Granted.doc

  

 
 
 CSE Symbol: IME
OTC PINK Symbol:  IMEXF
Frankfurt & Stuttgart Symbol: DPD2


 NR-2016-IME-29

 
 NEWS RELEASE Stock Options Granted
 
Vancouver, B.C. and Boston, MA, December 15, 2016 - Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt & Stuttgart
---> Symbol: DPD2) (the "Company") announced today that pursuant to the Company's Stock Option Plan, an aggregate of 750,0
--->00 shares have been granted to certain consultants and a director of the Company as incentive stock options.  200,000 
--->options have been granted at an exercise price of $0.08, and 550,000 options at an exercise price of $0.15 per share. 
--->   

About Imagin Medical
Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Co
--->mpany believes it will radically improve the way physicians detect cancer. Imagin's initial target market is bladder c
--->ancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a gr
--->eater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive
---> imaging technology is based upon improved optical designs and advanced light sensors. Learn more at www.imaginmedical
--->.com.
ON BEHALF OF THE BOARD:
 
Jim Hutchens,
President & CEO

For further information, contact:
Bill Galine, Investor Relations
Telephone: (775) 737-3292
Email: billgaline@gmail.com

CAUTIONARY DISCLAIMER STATEMENT:  The Canadian Securities Exchange has not reviewed and does not accept responsibility
---> for the adequacy or accuracy of the content of this news release.